T
Theriva Biologics D
D
TOVX
0.47170
USD
0.01
(2.17%)
مغلق
حجم التداول
299
الربح لكل سهم
-5
العائد الربحي
-
P/E
-0
حجم السوق
3,861,803
العنوان: Theriva Biologics Inc
القطاع: Healthcare
الصناعة: Biotechnology
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break downthe tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.